SCHEMBL9735209

SCHEMBL9735209

O=C(NO)c1ccccc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 6/20 0.56
PTGS2 P35354 5/20 0.53
CXCL8 P10145 3/20 0.53
PTGS1 P23219 3/20 0.53
TTR P02766 3/20 0.53
AKR1B10 O60218 2/20 0.53
ABCB11 O95342 2/20 0.53
MT-CO2 P00403 2/20 0.53
ADRA1A P35348 2/20 0.53
UGT1A9 O60656 1/20 0.53
TRPA1 O75762 1/20 0.53
ALB P02768 1/20 0.53
UGT1A6 P19224 1/20 0.53
UGT1A1 P22309 1/20 0.53
CXCR1 P25024 1/20 0.53
AGTR2 P50052 1/20 0.53
NR1I3 Q14994 1/20 0.53
SLC22A6 Q4U2R8 1/20 0.53
NR1H4 Q96RI1 1/20 0.53
UGT1A7 Q9HAW7 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10515184 0.85 PBRM1 (0.53) FTOPTGS2TTRMT-CO2ADRA1A
SCHEMBL374772 0.83 PTGS2 (0.55) FTOPTGS2CXCL8PTGS1TTR
SCHEMBL374641 0.83 FTO (0.71) FTOPTGS2PTGS1TTRAKR1B10
SCHEMBL10518206 0.83 MT-CO2 (0.73) PTGS2PTGS1TTRMT-CO2ADRA1A
SCHEMBL9734401 0.82 PTGS2 (0.75) FTOPTGS2CXCL8PTGS1TTR
SCHEMBL11407549 0.81 CXCL8 (0.55) FTOPTGS2CXCL8PTGS1TTR
SCHEMBL11518282 0.80 PTGS2 (0.56) FTOPTGS2CXCL8PTGS1TTR
SCHEMBL11451926 0.79 PTGS2 (0.72) FTOPTGS2CXCL8PTGS1TTR
SCHEMBL297513 0.78 POLB (0.72) HIF1AGAAMEN1KMT2ACYP1A2
Acetamide SCHEMBL27431923 0.78 CXCL8 (0.57) FTOPTGS2CXCL8PTGS1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155110-A Antiinflammatory agents, analgesics, antipyretics WARNER-LAMBERT COMPANY (US) 1992-10-13 US claimed
EP-0316630-A1 Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition WARNER-LAMBERT COMPANY (US) 1989-05-24 EP claimed
WO-1989003818-A1 NOVEL FENAMIC ACID HYDROXAMATE DERIVATIVES HAVING CYCLOOXYGENASE AND 5-LIPOXYGENASE INHIBITION WARNER-LAMBERT COMPANY (US) 1989-05-05 WO claimed
US-5155110-A Antiinflammatory agents, analgesics, antipyretics WARNER-LAMBERT COMPANY (US) 1992-10-13 US disclosed
EP-0316630-A1 Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition WARNER-LAMBERT COMPANY (US) 1989-05-24 EP disclosed
WO-1989003818-A1 NOVEL FENAMIC ACID HYDROXAMATE DERIVATIVES HAVING CYCLOOXYGENASE AND 5-LIPOXYGENASE INHIBITION WARNER-LAMBERT COMPANY (US) 1989-05-05 WO disclosed